Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Location » Vermont

Bennington, Vermont Clinical Trials

Alzheimer's Disease

Research Site

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

Research Site

A clinical research study for the treatment of Alzheimer's Disease

Research Site

A clinical trial to evaluate treatments using AVP-923 (dextromethorphan/quinidine) and Placebo for patients with Agitation or Alzheimer's Disease

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Patients are needed to participate in a clinical research study evaluating Solanezumab and Placebo for the treatment of Alzheimer's Disease

Pfizer Investigational Site Updated

A Phase 2 clinical study for patients with Alzheimer's Disease

View More »

The Memory Clinic

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Dementia

Research Site

A Phase 3 clinical study for patients with Alzheimer's Disease or Dementia

The Memory Clinic

A clinical research study of TRx0237 and Placebo for the treatment of Behavioral Variant Frontotemporal Dementia (bvFTD)

The Memory Clinic

Patients are needed to participate in a clinical research study evaluating TRx0237 200 mg/day and Placebo for the treatment of Alzheimer's Disease

Diabetes Mellitus, Type 1

Novo Nordisk Clinical Trial Call Center Updated

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 2

Research Site Updated

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Novo Nordisk Clinical Trial Call Center

A clinical research study of insulin degludec and insulin glargine for the treatment of Diabetes or Diabetes Mellitus, Type 2

Research Site

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Heart Attack (Myocardial Infarction)

Research Site

Patients are needed to participate in a clinical research study of Dapagliflozin 10 mg and Placebo tablet to evaluate Diabetes Mellitus, Non-Insulin-Dependent or High Risk for Cardiovascular Event

Kidney Disease

Research Site Updated

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies